Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
11/16/2011 | EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors |
11/16/2011 | EP2386540A1 Novel compounds, their preparation and use |
11/16/2011 | EP2386311A1 Compositions for improving lipid metabolism |
11/16/2011 | EP2386305A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues |
11/16/2011 | EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues |
11/16/2011 | EP2385830A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor |
11/16/2011 | EP2142533B1 Imidazolidinone derivatives |
11/16/2011 | EP1962826B1 Method for weight reduction |
11/16/2011 | EP1948149B1 Formulation comprising metformin and vildagliptin |
11/16/2011 | EP1924262B1 Methods and formulations for modulating lyn kinase activity and treating related disorders |
11/16/2011 | EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
11/16/2011 | EP1455588B1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
11/16/2011 | CN1757637B Method for purifying VE nicotinate raw material |
11/16/2011 | CN102246030A A method of characterizing phytochemicals from trigonella foenum graceum |
11/16/2011 | CN102245758A Materials and methds to enhance hematopoietic stem cells engraftment procedures |
11/16/2011 | CN102245642A Conjugates of GLP-1 agonists and uses thereof |
11/16/2011 | CN102245641A High affinity human antibodies to PCSK9 |
11/16/2011 | CN102245633A Novel insulin analogues |
11/16/2011 | CN102245626A Mini-hepcidin peptides and methods of using thereof |
11/16/2011 | CN102245608A Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
11/16/2011 | CN102245600A Pyrrolone melanin concentrating hormone receptor-1 antagonists |
11/16/2011 | CN102245581A Tetrahydrotriazine compounds for treating diseases associated with AMPK activity |
11/16/2011 | CN102245574A Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
11/16/2011 | CN102245573A Heteroaryl derivatives as cftr modulators |
11/16/2011 | CN102245187A Modulation of TOLL-like receptor 3 expression by antisense oligonucleotides |
11/16/2011 | CN102245185A Combination of insulin with triazine derivatives and its use for treating diabetes |
11/16/2011 | CN102245183A New compounds v |
11/16/2011 | CN102245172A Oral formulations containing metformin and a-glycosidase inhibitor, and preparation method thereof |
11/16/2011 | CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product |
11/16/2011 | CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof |
11/16/2011 | CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
11/16/2011 | CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof |
11/16/2011 | CN102241785A Production technology of purslane polysaccharide |
11/16/2011 | CN102241710A Salidroside analogues as well as preparation method and application thereof |
11/16/2011 | CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
11/16/2011 | CN102241644A Alpha-azyl-3-aryl propionamido thiazole derivative, preparation method and purpose thereof |
11/16/2011 | CN102241633A Linolenic acid-carnosine composite and preparation method thereof |
11/16/2011 | CN102240405A Apolipoprotein A-I (ApoA-I) milano genetic medicine |
11/16/2011 | CN102240397A Production of high mannose proteins in plant culture |
11/16/2011 | CN102240371A Medicine for treating diabetes mellitus and preparation method thereof |
11/16/2011 | CN102240358A Chinese medicinal blood fat removing and blood stasis eliminating mixture for treating hyperlipemia |
11/16/2011 | CN102240343A Environment-friendly preparation method for high-ester catechin tea polyphenol |
11/16/2011 | CN102240340A Method for processing prepared rehmannia root |
11/16/2011 | CN102240332A Pharmaceutical composition and application thereof |
11/16/2011 | CN102240312A Application of drugs by using inula britannica total flavone extract for reducing blood sugar |
11/16/2011 | CN102240310A Blood-sugar-reducing composition and preparation method thereof |
11/16/2011 | CN102240309A Application of valeriana jatamansi jones or extracts thereof in preparation of medicine for lowering fat and protecting liver |
11/16/2011 | CN102240307A Preparation method of ginkgo leaf extract |
11/16/2011 | CN102240306A Process for extracting proanthocyanidins from pine cone shells |
11/16/2011 | CN102240302A Chinese medicine composition of super gene active peptide |
11/16/2011 | CN102240299A Improved intravenously dripped multi-vitamin injection |
11/16/2011 | CN102240293A Application of echinocystic acid in preparing medicament preventing and treating cardiovascular diseases |
11/16/2011 | CN102240278A Methods, assays and compositions for treating retinol-related diseases |
11/16/2011 | CN102240040A Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
11/16/2011 | CN102240037A Amino acid and calcium composite powder |
11/16/2011 | CN101891831B Method for preparing stable slow-digestion starch |
11/16/2011 | CN101884665B Traditional Chinese medicine extract with alpha-glucuroide and xanthine oxidase inhibiting effect and preparation method and usage thereof |
11/16/2011 | CN101869687B Medicament for treating fatty liver and alcohol liver, and reducing blood lipid and aminotransferase |
11/16/2011 | CN101849932B Nutrient preparation of iron and zinc and preparation method thereof |
11/16/2011 | CN101797312B Method for preparing Alisma extract capable of inhibiting alpha-glucuroide activity |
11/16/2011 | CN101756962B Compound nateglinide valsatan medicinal composition |
11/16/2011 | CN101659700B Short peptide |
11/16/2011 | CN101654487B Preparation method for vanadium polysaccharide complex and application thereof |
11/16/2011 | CN101627973B Calcium acetate tablet and preparation method thereof |
11/16/2011 | CN101580755B Process for continuously extracting cordyceps militaris essential oil, cordycepin, cordycepic acid and cordyceps militaris polysaccharide from cordyceps militaris |
11/16/2011 | CN101559081B Application of river clam extract in preparation of medicament for curing and preventing diabetes mellitus |
11/16/2011 | CN101502559B Method for continuously extracting effective ingredients from Semen cassiae under high pressure |
11/16/2011 | CN101484428B Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-HSD 1) |
11/16/2011 | CN101448791B Fxr agonists |
11/16/2011 | CN101411791B Method for preparing total flavones from leaf of Belamcanda rhizome and use |
11/16/2011 | CN101365442B Use of benzo-fused heterocycle sulfamide derivatives for preparing medicine for the treatment of obesity |
11/16/2011 | CN101365441B Use of benzo-fused heterocycle sulfamide derivatives for preparing medicine for lowering lipids and lowering blood glucose levels |
11/16/2011 | CN101357144B Selaginella uncinata extraction, its preparation method and application |
11/16/2011 | CN101326954B Method for producing feed containing Ganoderma lucidum acid from wheat straw transformed by Ganoderma lucidum and uses therefor |
11/16/2011 | CN101302245B Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof |
11/16/2011 | CN101249129B Chinese medicine extract combination and medicine use thereof |
11/16/2011 | CN101166529B Benzotriazole derivatives as cannabinoid receptor antagonists |
11/16/2011 | CN101095942B Formulation of the Exendin injection medicine containing stabilizing agent |
11/16/2011 | CN101010320B Aminotropane derivatives, preparation thereof and therapeutic use thereof |
11/15/2011 | US8058426 Phosphorus-containing compounds and uses thereof |
11/15/2011 | US8058425 Purine derivatives as kinase inhibitors |
11/15/2011 | US8058400 Composition and method for modulating dendritic cell-t cell interaction |
11/15/2011 | US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
11/15/2011 | US8058277 Substituted indoles |
11/15/2011 | US8058267 Steroids as agonists for FXR |
11/15/2011 | US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
11/15/2011 | US8058233 Modification of feeding behavior using PYY and GLP-1 |
11/15/2011 | US8057825 Krill extracts for treatment of cardiovascular diseases |
11/15/2011 | US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering |
11/15/2011 | CA2624123C Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose |
11/15/2011 | CA2488611C Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
11/15/2011 | CA2479126C Combination treatments for chemokine-mediated diseases |
11/15/2011 | CA2469612C Treatment of statin side effects using uridine derivatives |
11/15/2011 | CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
11/15/2011 | CA2429979C Treatment of statin side effects |
11/10/2011 | WO2011140328A1 Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof |
11/10/2011 | WO2011140267A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
11/10/2011 | WO2011140232A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
11/10/2011 | WO2011140208A2 Methods and compositions for diagnosing and treating autoimmune disorders |
11/10/2011 | WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase |